Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Here is the eligibility information in plain English:
Who might be able to join this trial:
- People who carry the sickle cell trait (meaning they carry one copy of the sickle cell gene but may not have the full disease)
- People who have a blood disorder involving one or two sickle cell genes (such as sickle cell disease)
- Healthy people who are willing to take part as comparison volunteers
- Adults aged 18 years or older
Who may not be able to join:
- People who are not able to understand the research nature of this study and what it involves
- People who have HIV, Hepatitis B, or Hepatitis C cannot take part for safety reasons related to handling blood samples
- People who have not already been enrolled in another NIH research study where HIV, Hepatitis B, and Hepatitis C screening has already been carried out (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: William A Eaton, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phone: (301) 496-6030
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To screen large compound libraries for anti-sickling activity, particularly compounds that are already FDA-approved drugs, with the goal of discovering a drug for treating sickle cell disease.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.